Drugmakers from Pfizer to GSK to hike U.S. costs on over 200 medicine


Drugmakers together with Pfizer Inc , GlaxoSmithKline PLC and Sanofi SA are planning to hike U.S. checklist costs on greater than 200 medicine in the US on Wednesday, in accordance with drugmakers and information analyzed by healthcare analysis agency three Axis Advisors.





Supply hyperlink